These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 24685455)

  • 21. Oritavancin - a new semisynthetic lipoglycopeptide agent to tackle the challenge of resistant gram positive pathogens.
    Das B; Sarkar C; Schachter J
    Pak J Pharm Sci; 2013 Sep; 26(5):1045-55. PubMed ID: 24035967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance.
    Zeng D; Debabov D; Hartsell TL; Cano RJ; Adams S; Schuyler JA; McMillan R; Pace JL
    Cold Spring Harb Perspect Med; 2016 Dec; 6(12):. PubMed ID: 27663982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycopeptides in clinical development: pharmacological profile and clinical perspectives.
    Van Bambeke F
    Curr Opin Pharmacol; 2004 Oct; 4(5):471-8. PubMed ID: 15351351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semisynthetic glycopeptides: chemistry, structure-activity relationships and prospects.
    Ciabatti R; Malabarba A
    Farmaco; 1997 May; 52(5):313-21. PubMed ID: 9274002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complexation of peptidoglycan intermediates by the lipoglycodepsipeptide antibiotic ramoplanin: minimal structural requirements for intermolecular complexation and fibril formation.
    Cudic P; Kranz JK; Behenna DC; Kruger RG; Tadesse H; Wand AJ; Veklich YI; Weisel JW; McCafferty DG
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7384-9. PubMed ID: 12032292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
    J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mode of action of Van-M-02, a novel glycopeptide inhibitor of peptidoglycan synthesis, in vancomycin-resistant bacteria.
    Miura K; Yamashiro H; Uotani K; Kojima S; Yutsudo T; Lu J; Yoshida O; Yamano Y; Maki H; Arimoto H
    Antimicrob Agents Chemother; 2010 Feb; 54(2):960-2. PubMed ID: 19933802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to glycopeptide antibiotics in the teicoplanin producer is mediated by van gene homologue expression directing the synthesis of a modified cell wall peptidoglycan.
    Beltrametti F; Consolandi A; Carrano L; Bagatin F; Rossi R; Leoni L; Zennaro E; Selva E; Marinelli F
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1135-41. PubMed ID: 17220405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the target sites and mechanisms of action of glycopeptide and lipoglycodepsipeptide antibiotics.
    Reynolds PE; Somner EA
    Drugs Exp Clin Res; 1990; 16(8):385-9. PubMed ID: 2151441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Battle against Vancomycin-Resistant Bacteria: Recent Developments in Chemical Strategies.
    Dhanda G; Sarkar P; Samaddar S; Haldar J
    J Med Chem; 2019 Apr; 62(7):3184-3205. PubMed ID: 30404451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Affinity adsorbents for the vancomycin group of antibiotics.
    Yan H; Zhao Q; Yuan J; Cheng X; He B
    Biotechnol Appl Biochem; 2000 Feb; 31(1):15-20. PubMed ID: 10669398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.
    Wu ZC; Boger DL
    Acc Chem Res; 2020 Nov; 53(11):2587-2599. PubMed ID: 33138354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile.
    Henson KE; Levine MT; Wong EA; Levine DP
    Expert Rev Anti Infect Ther; 2015; 13(10):1265-78. PubMed ID: 26165756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational analysis of bacterial cell wall peptides indicates how particular conformations have influenced the evolution of penicillin-binding proteins, beta-lactam antibiotics and antibiotic resistance mechanisms.
    Grail BM; Payne JW
    J Mol Recognit; 2002; 15(3):113-25. PubMed ID: 12203837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elucidation of the active conformation of vancomycin dimers with antibacterial activity against vancomycin-resistant bacteria.
    Nakamura J; Yamashiro H; Hayashi S; Yamamoto M; Miura K; Xu S; Doi T; Maki H; Yoshida O; Arimoto H
    Chemistry; 2012 Oct; 18(40):12681-9. PubMed ID: 22915313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure, biochemistry and mechanism of action of glycopeptide antibiotics.
    Reynolds PE
    Eur J Clin Microbiol Infect Dis; 1989 Nov; 8(11):943-50. PubMed ID: 2532132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desleucyl-Oritavancin with a Damaged d-Ala-d-Ala Binding Site Inhibits the Transpeptidation Step of Cell-Wall Biosynthesis in Whole Cells of Staphylococcus aureus.
    Kim SJ; Singh M; Sharif S; Schaefer J
    Biochemistry; 2017 Mar; 56(10):1529-1535. PubMed ID: 28221772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of transglycosylation involved in bacterial peptidoglycan synthesis.
    Goldman RC; Gange D
    Curr Med Chem; 2000 Aug; 7(8):801-20. PubMed ID: 10828288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. II. Antibacterial activity of N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin.
    Plattner JJ; Chu D; Mirchink EP; Isakova EB; Preobrazhenskaya MN; Olsufyeva EN; Miroshnikova OV; Printsevskaya SS
    J Antibiot (Tokyo); 2007 Apr; 60(4):245-50. PubMed ID: 17456974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging peptidoglycan biosynthesis in Bacillus subtilis with fluorescent antibiotics.
    Tiyanont K; Doan T; Lazarus MB; Fang X; Rudner DZ; Walker S
    Proc Natl Acad Sci U S A; 2006 Jul; 103(29):11033-8. PubMed ID: 16832063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.